Founded Date: 2019-01-01
Last Funding Type: Series B
Headquarters: Watertown, Massachusetts, United States
Investors Number: 17.0
Technology: Biotechnology, Health Care, Medical
Employee Number: 10001+
Industry: End-to-End Drug Development
Last Funding Date: 2022-10-11
Funding Status: Early Stage Venture
Total Funding: 612000000.0